Foguth Wealth Management’s FT Vest US Equity Enhance & Moderate Buffer ETF December XDEC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$324K Sell
7,578
-31
-0.4% -$1.27K 0.04% 151
2025
Q4
$312K Buy
+7,609
New +$308K 0.05% 126
2025
Q2
$305K Sell
7,847
-4,461
-36% -$166K 0.07% 110
2025
Q1
$453K Sell
12,308
-1,814
-13% -$67.9K 0.11% 89
2024
Q4
$535K Buy
14,122
+2,091
+17% +$77.5K 0.14% 78
2024
Q3
$442K Sell
12,031
-55
-0.5% -$2K 0.16% 79
2024
Q2
$436K Sell
12,086
-10,379
-46% -$368K 0.19% 71
2024
Q1
$792K Buy
+22,465
New +$779K 0.42% 53

Other funds holding XDEC

Foguth Wealth Management's XDEC Position: Q1 2026 in Review

Foguth Wealth Management reduced its FT Vest US Equity Enhance & Moderate Buffer ETF December (XDEC) stake by 0.41% in Q1 2026, selling an estimated $1.27K and leaving 7,578 shares worth $324K. The position accounts for 0.04% of the portfolio, ranked #151.

Foguth Wealth Management first reported a position in XDEC in Q1 2024 and has held it in 8 quarters since. The position peaked at $792K in Q1 2024. 83 funds tracked by Wall St. Rank hold XDEC as of Q1 2026.

  • Foguth Wealth Management held 7,578 shares of FT Vest US Equity Enhance & Moderate Buffer ETF December worth $324K as of Q1 2026.
  • Foguth Wealth Management sold 31 FT Vest US Equity Enhance & Moderate Buffer ETF December shares in Q1 2026, an estimated $1.27K.
  • FT Vest US Equity Enhance & Moderate Buffer ETF December made up 0.04% of Foguth Wealth Management's portfolio in Q1 2026, its #151 holding.
  • Foguth Wealth Management first reported a position in FT Vest US Equity Enhance & Moderate Buffer ETF December in Q1 2024 and has held it in 8 quarters since.
  • Foguth Wealth Management's FT Vest US Equity Enhance & Moderate Buffer ETF December position peaked at $792K in Q1 2024.
  • 83 funds tracked by Wall St. Rank held FT Vest US Equity Enhance & Moderate Buffer ETF December as of Q1 2026.

Based on Foguth Wealth Management's 13F filing for Q1 2026, filed 1 Jun 2026.